norethindrone acetate has been researched along with Cardiovascular Diseases in 27 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A mixed effect profile of HRT on the state of inflammation (increase in CRP and homocysteine, decrease in fibrinogen) was observed." | 5.14 | Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women. ( Bingol, B; Biri, A; Gunenc, Z; Güner, H; Tiras, B; Yilmaz, M, 2010) |
| " Since both estrogen and progestogen seem to be responsible in the etiology of hypertension the lowest possible dosage of OC should be chosen." | 2.36 | Oestrogens and hypertension. ( Roberts, JM, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (14.81) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 15 (55.56) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, X | 1 |
| Cai, S | 1 |
| Li, G | 1 |
| Prabahar, K | 1 |
| Hernández-Wolters, B | 1 |
| Yin, Y | 1 |
| Lakryc, EM | 1 |
| Machado, RB | 1 |
| Soares, JM | 1 |
| Fernandes, CE | 1 |
| Baracat, EC | 1 |
| Johansen, OE | 1 |
| Qvigstad, E | 1 |
| Bruce, D | 1 |
| Frick, A | 1 |
| Rymer, J | 1 |
| Robinson, J | 1 |
| Ylikorkala, O | 1 |
| Tsvetkov, K | 1 |
| Monastirska, M | 1 |
| Angelova, M | 1 |
| Bingol, B | 1 |
| Gunenc, Z | 1 |
| Yilmaz, M | 1 |
| Biri, A | 1 |
| Tiras, B | 1 |
| Güner, H | 1 |
| Jamin, C | 1 |
| Poncelet, C | 1 |
| Madelenat, P | 1 |
| Scott, AR | 1 |
| Dhindsa, P | 1 |
| Forsyth, J | 1 |
| Mansell, P | 1 |
| Stevenson, JC | 2 |
| Oladipo, A | 1 |
| Manassiev, N | 1 |
| Whitehead, MI | 2 |
| Guilford, S | 1 |
| Proudler, AJ | 1 |
| D'Anna, R | 1 |
| Baviera, G | 1 |
| Corrado, F | 1 |
| Cancellieri, F | 1 |
| Crisafulli, A | 1 |
| Squadrito, F | 1 |
| Bergstrøm, H | 1 |
| Tonstad, S | 1 |
| Brosnan, JF | 1 |
| Sheppard, BL | 1 |
| Norris, LA | 1 |
| Odabasi, AR | 1 |
| Yuksel, H | 1 |
| Karul, A | 1 |
| Kozaci, D | 1 |
| Sezer, SD | 1 |
| Onur, E | 1 |
| Kay, CR | 1 |
| Wynn, V | 1 |
| Niththyananthan, R | 1 |
| Meade, TW | 1 |
| Roberts, JM | 1 |
| Mück, AO | 1 |
| Salbach, B | 1 |
| Rabe, T | 1 |
| von Holst, T | 1 |
| Runnebaum, B | 1 |
| Taskinen, MR | 2 |
| Crook, D | 1 |
| Godsland, IF | 1 |
| Lees, B | 1 |
| Puolakka, J | 1 |
| Pyörälä, T | 1 |
| Luotola, H | 1 |
| Bjäörn, M | 1 |
| Kääriänen, J | 1 |
| Lahdenperä, S | 1 |
| Ehnholm, C | 1 |
| Kennedy, G | 1 |
| McLaren, M | 1 |
| Belch, JJ | 1 |
| Seed, M | 1 |
| Davidson, MH | 1 |
| Maki, KC | 1 |
| Marx, P | 1 |
| Maki, AC | 1 |
| Cyrowski, MS | 1 |
| Nanavati, N | 1 |
| Arce, JC | 1 |
| Sørensen, MB | 1 |
| Fritz-Hansen, T | 1 |
| Jensen, HH | 1 |
| Pedersen, AT | 1 |
| Højgaard, L | 1 |
| Ottesen, B | 1 |
| Sendağ, F | 2 |
| Terek, MC | 1 |
| Karadadaş, N | 2 |
| Bilgin, O | 2 |
| Christodoulakos, G | 1 |
| Panoulis, C | 1 |
| Kouskouni, E | 1 |
| Chondros, C | 1 |
| Dendrinos, S | 1 |
| Creatsas, G | 1 |
| Ozsener, S | 1 |
4 reviews available for norethindrone acetate and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of Transdermal 17β-Estradiol + Norethisterone Acetate on Cardiovascular Disease Risk Factors in Postmenopausal Women: A Meta-analysis of Data From Randomized, Controlled Trials.
Topics: Administration, Cutaneous; Blood Glucose; Body Weight; Cardiovascular Diseases; Cholesterol, LDL; Es | 2023 |
Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
Topics: Antidepressive Agents; Breast Neoplasms; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Do | 2008 |
[Tibolone].
Topics: Adult; Aged; Animals; Blood Coagulation; Breast; Cardiovascular Diseases; Controlled Clinical Trials | 2002 |
Oestrogens and hypertension.
Topics: Adolescent; Adult; Age Factors; Angiotensin II; Cardiac Output; Cardiovascular Diseases; Contracepti | 1981 |
18 trials available for norethindrone acetate and Cardiovascular Diseases
| Article | Year |
|---|---|
What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?
Topics: Age Factors; Brazil; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Drug Combinat | 2015 |
A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2.
Topics: Cardiovascular Diseases; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; | 2008 |
[Using pausogest for hormone replacement therapy--effect on plasma lipoproteins in menopause women].
Topics: Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; | 2008 |
Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Carbohydrate Metabolism; Cardiovascular Diseases; Est | 2010 |
Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes.
Topics: Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabe | 2004 |
Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
Topics: Administration, Cutaneous; Adult; Anthropometry; Biomarkers; Blood Glucose; Cardiovascular Diseases; | 2004 |
The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
Topics: C-Reactive Protein; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Genist | 2005 |
Combined hormone replacement therapy improves lipids but may increase leucocytes.
Topics: Administration, Oral; Adult; Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Cholinerg | 2006 |
Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
Topics: Administration, Cutaneous; Administration, Oral; Aged; alpha-2-Antiplasmin; Antigens; Antithrombins; | 2007 |
Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease.
Topics: Body Composition; Body Mass Index; Cardiovascular Diseases; Estradiol; Female; Hormone Replacement T | 2007 |
Oral versus transdermal hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Blood Glucose; Bone Density; Cardiovascular Disease | 1993 |
Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
Topics: Administration, Cutaneous; Administration, Oral; Cardiovascular Diseases; Drug Combinations; Estradi | 1996 |
Elevated levels of sE-selectin in post-menopausal females are decreased by hormone replacement therapy to levels observed in pre-menopausal females.
Topics: Adult; Aged; Cardiovascular Diseases; Drug Synergism; E-Selectin; Endothelium, Vascular; Estradiol; | 1999 |
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
Topics: Aged; Apolipoprotein A-I; Blood Coagulation Factors; Blood Glucose; C-Peptide; Cardiovascular Diseas | 2000 |
Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement.
Topics: Blood Pressure; Cardiovascular Diseases; Cerebrovascular Circulation; Cross-Over Studies; Double-Bli | 2001 |
Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
Topics: Administration, Cutaneous; Administration, Oral; Cardiovascular Diseases; Carotid Artery, Internal; | 2001 |
Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis.
Topics: Cardiovascular Diseases; Double-Blind Method; Endothelin-1; Epoprostenol; Estradiol; Estrogen Replac | 2002 |
Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; | 2002 |
5 other studies available for norethindrone acetate and Cardiovascular Diseases
| Article | Year |
|---|---|
Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, | 1982 |
The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, | 1982 |
Effects of progestogens on the cardiovascular system.
Topics: Adult; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Ora | 1982 |
[Serum lipids in treatment with transdermal estradiol and oral norethisterone acetate].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Cardiovascular Diseases; Cholesterol; | 1995 |
Postmenopausal hormone replacement therapy and plasma lipoproteins.
Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Double-Blind Method; Drug Combinations; Estrogen Re | 1995 |